BioSpace News Archive

Hospital information system is comprehensive information system designed to manage all the aspects of a hospital’s operation, such as administrative, medical, legal and financial concerns and the corresponding processing of services.

Neuroendovascular coiling is performed to prevent the blood flow in an aneurysm. An aneurysm is the excessive enlargement of blood vessels lead to a weakness of the blood vessel wall.

Aurealis Therapeutics and Xbiome announced that the two companies have entered into an exclusive license and collaboration agreement for the clinical development and commercialization of Aurealis investigational Diabetic Foot Ulcer, other chronic wounds, and inflammatory disease therapy AUP-16 in Greater China.

BeiGene announced that the Center for Drug Evaluation of the China National Medical Products Administration has accepted a supplemental new drug application for BeiGene’s BTK inhibitor BRUKINSA as a treatment for adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma and granted BRUKINSA breakthrough therapy designation.

Amryt Announces Oleogel-S10 EMA Regulatory Update.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced the voluntary withdrawal of the supplemental Biologics License Application (sBLA) for Libtayo ® (cemiplimab-rwlc) as a second-line treatment for patients with advanced cervical cancer.

Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi (lisocabtagene maraleucel) for Relapsed or Refractory DLBCL, PMBCL and FL3B.

Alterity Therapeutics today announced that data in an animal model of Multiple System Atrophy (MSA) were published in the Journal of Parkinson’s Disease. MSA is a devastating neurodegenerative disorder without approved therapy.

MyChem’s nucleotide synthesis methods are highly complementary to Maravai’s TriLink mRNA technologies Increases capabilities serving the high-growth cell and gene therapy market.

Novoron Bioscience announced today that they have been awarded an NIA/NIH grant to advance their work into Alzheimer’s Disease (AD), chronic traumatic encephalopathy (CTE), and other tauopathies.